Results 291 to 300 of about 3,684,448 (359)

Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. [PDF]

Front Public Health
Lewandrowski KU, Blum K, Lewandrowski APL, Thanos PK, Pinhasov A, Sharafshah A, Baron D, Gold MS, Dennen CA, Elman I, Bowirrat A, Modestino EJ, Zeine F, Jafari N, Sunder K, Makale MT, Giordano J, Gondre-Lewis MC, Lindenau M, Fuehrlein BS, Badgaiyan RD, Levin C, Schmidt SL, Fiorelli RKA.   +23 more
europepmc   +1 more source

Cannabidiol in autism: Clinical pharmacology priorities for trial design

British Journal of Clinical Pharmacology, EarlyView.
Gislei Frota Aragão, Carla Barbosa Brandão, José Evaldo Leandro Júnior   +2 more
wiley   +1 more source

NO Time to Die: Nitric Oxide's Ongoing Relevance in Mental Disorders. [PDF]

Biol Psychiatry Glob Open Sci
Freudenberg F.
europepmc   +1 more source

Mental Health and Care Denial in Transgender Youth. [PDF]

JAMA Psychiatry
Eckstrand KL, Fonseca EF, Baker K, Dalke K.   +3 more
europepmc   +1 more source

Research in biological psychiatry in India.

, 2002
V. Palaniappun
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders

World Journal of Biological Psychiatry, 2022
Aim This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Posttraumatic Stress Disorders (published in 2002 ...
B. Bandelow, C. Allgulander, D. Baldwin, Daniel L. C. Costa, D. Denys, N. Dilbaz, K. Domschke, E. Eriksson, N. Fineberg, J. Hättenschwiler, E. Hollander, H. Kaiya, T. Karavaeva, S. Kasper, M. Katzman, Yong-Ku Kim, Takeshi Inoue, L. Lim, V. Masdrakis, J. Menchón, E. Miguel, H. Möller, A. Nardi, S. Pallanti, Giampaolo Robert Perna, D. Rujescu, V. Starcevic, D. Stein, S. Tsai, M. Van Ameringen, A. Vasileva, Zhen Wang, J. Zohar   +32 more
semanticscholar   +1 more source

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD

World Journal of Biological Psychiatry, 2022
Aim This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Posttraumatic Stress Disorders which was published in ...
B. Bandelow, C. Allgulander, D. Baldwin, Daniel L. C. Costa, D. Denys, N. Dilbaz, K. Domschke, E. Hollander, S. Kasper, H. Möller, E. Eriksson, N. Fineberg, J. Hättenschwiler, H. Kaiya, T. Karavaeva, M. Katzman, Yong-Ku Kim, Takeshi Inoue, L. Lim, V. Masdrakis, J. Menchón, E. Miguel, A. Nardi, S. Pallanti, Giampaolo Robert Perna, D. Rujescu, V. Starcevic, Dan J Stein, S. Tsai, M. Van Ameringen, A. Vasileva, Zhen Wang, J. Zohar   +32 more
semanticscholar   +1 more source

Biological psychiatry in Korea

International Review of Psychiatry, 2008
Since the mid 1980s, the biological field of psychiatry has developed rapidly in Korea. Currently there are more than ten research societies in field of biological psychiatry including the Korean Society of Biological Psychiatry, the Korean Academy of Schizophrenia, and the Korean Society for Depressive and Bipolar disorders.
Young-Cho, Chung, Seung-Hwan, Lee
openaire   +2 more sources